Advanced Search

Share

English Português

Latest issue

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

1.6

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

2.0

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

0.360

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

0.754

Time to first decision

The median number of days it takes for an article to go from submission to first editorial decision.

See more

Time to first decision

33 days

View more metrics

Open Access Option

Journal Information

Most popular

Articles that have received the most social media attention. Number of times they have been referenced in the last 3 years.

846

Equity program: strategies on clinical studies as an aggregating potential

Edvan de Queiroz Crusoe, Abrahão Elias Hallack Neto, Deise Ferreira Nantes, Eduardo Flavio Oliveira Ribeiro, Fernando Monteiro Correia Pinto, Jaisson Andre Pagnoncelli Bortolini, James Farley Rafael Maciel, Jose Francisco Comenalli Marques Junior, ... Renato Luiz Guerino Cunha

Hematol Transfus Cell Ther. 2023;45:417-8

846

Full text access

Share

237

Progressive multifocal leukoencephalopathy in a patient with relapsed chronic lymphocytic leukemia treated with Ibrutinib

Larissa Lane Cardoso Teixeira, Viviane Regina Hernandez Nunes, Guilherme Fleury Perini, Carolina Cristina Pellegrino Feres, Danielle Ovigli, Nelson Hamerschlak

Hematol Transfus Cell Ther. 2022;44:437-9

237

Open access

Share

218

Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literature

Bruno Almeida Costa, Kaiza Vilarinho da Luz, Sarah Emanuelle Viana Campos, Germison Silva Lopes, João Paulo de Vasconcelos Leitão, Fernando Barroso Duarte

Hematol Transfus Cell Ther. 2022;44:26-31

218

Full text access

Share

144

Hemoglobin value may be decreased in patients with severe coronavirus disease 2019

Giuseppe Lippi, Camilla Mattiuzzi

Hematol Transfus Cell Ther. 2020;42:116-7

144

Open access

Open Article

Share

134

GATA2 variants in patients with non-tuberculous mycobacterial or fungal infections without known immunodeficiencies

Daniela P. Mendes-de-Almeida, Francianne G. Andrade, Filipe V. dos Santos-Bueno, Dayvison F. Saraiva Freitas, Sheila C. Soares-Lima, Rosely M. Zancopé-Oliveira, Maria S. Pombo-de-Oliveira

Hematol Transfus Cell Ther. 2023;45:211-6

134

Full text access

Share

121

A functional interaction between the CCR5 and CD34 molecules expressed in hematopoietic cells can support (or even promote) the development of cancer

Bruna Kulmann-Leal, Joel Henrique Ellwanger, José Artur Bogo Chies

Hematol Transfus Cell Ther. 2020;42:70-6

121

Open access

Share

108

PILOMATRIX CARCINOMA WAS BEYOND ANY EXPECTATIONS: A CASE REPORT OF CARCINOMA CLINICIAN SHOULD BE AWARE OF IT

Abdalraouf Omar, Suad Elnnami, Ibtihaj Hassan

Hematol Transfus Cell Ther. 2021;43 Supl 3:S52

108

Open access

Share

104

High prevalence of serological weak D phenotype and preponderance of weak D type 4.0.1. genetic variant in a Nigerian population: implications for transfusion practice in a resource-limited setting

Dauda Usman Maryam, Isyaku Gwarzo Mukhtar, Aminu Abba Yusuf, Ahmed Ibrahim Salisu

Hematol Transfus Cell Ther. 2022;44:386-91

104

Open access

Share

83

A retrospective cohort study to screen linezolid-induced thrombocytopenia in adult patients hospitalized in the Midwestern Region of Brazil

Letícia Souza Lima, Eliana da Costa Alvarenga Brito, Karine Mattos, Eduardo Benedetti Parisotto, Renata Trentin Perdomo, Simone Schneider Weber

Hematol Transfus Cell Ther. 2020;42:230-7

83

Open access

Share

61

Plan for blood banks to protect blood donors and healthcare workers during COVID-19 pandemic

Sheikh Muhammad Ebad Ali, Sarosh Fatima

Hematol Transfus Cell Ther. 2020;42:316-7

61

Open access

Open Article

Share

Idiomas

Hematology, Transfusion and Cell Therapy